Your browser doesn't support javascript.
loading
Renoprotective effects of empagliflozin are linked to activation of the tubuloglomerular feedback mechanism and blunting of the complement system.
Chen, Xin; Delic, Denis; Cao, Yaochen; Shen, Linghong; Shao, Qin; Zhang, Zheyu; Wu, Hongwei; Hasan, Ahmed A; Reichetzeder, Christoph; Gaballa, Mohamed M S; Krämer, Bernhard K; Klein, Thomas; Yin, Lianghong; He, Ben; Morgera, Stanislao; Hocher, Berthold.
Afiliação
  • Chen X; Department of Nephrology, Charité-Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.
  • Delic D; Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology/Pneumology), University Medical Centre Mannheim, University of Heidelberg, Heidelberg, Germany.
  • Cao Y; The First Clinical Medical College of Jinan University, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China.
  • Shen L; Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology/Pneumology), University Medical Centre Mannheim, University of Heidelberg, Heidelberg, Germany.
  • Shao Q; Department of Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
  • Zhang Z; Department of Nephrology, Charité-Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.
  • Wu H; Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology/Pneumology), University Medical Centre Mannheim, University of Heidelberg, Heidelberg, Germany.
  • Hasan AA; Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • Reichetzeder C; Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  • Gaballa MMS; The First Clinical Medical College of Jinan University, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China.
  • Krämer BK; The First Clinical Medical College of Jinan University, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China.
  • Klein T; Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology/Pneumology), University Medical Centre Mannheim, University of Heidelberg, Heidelberg, Germany.
  • Yin L; Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
  • He B; Department of Pathology, HMU - Health and Medical University, Potsdam, Germany.
  • Morgera S; Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology/Pneumology), University Medical Centre Mannheim, University of Heidelberg, Heidelberg, Germany.
  • Hocher B; Faculty of Veterinary Medicine, Benha University, Toukh, Egypt.
Am J Physiol Cell Physiol ; 324(4): C951-C962, 2023 04 01.
Article em En | MEDLINE | ID: mdl-36779666
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Renal Crônica / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials Limite: Animals Idioma: En Revista: Am J Physiol Cell Physiol Assunto da revista: FISIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Renal Crônica / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials Limite: Animals Idioma: En Revista: Am J Physiol Cell Physiol Assunto da revista: FISIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha